On the morning of May 6, 2023, Central Veterinary Medicine Joint Stock Company I (VINAVETCO) held its Annual General Meeting of Shareholders (AGM) for 2023 at Binh Luong Industrial Cluster, Tan Quang Commune, Van Lam District, Hung Yen Province.

By the company’s charter, the resolutions were approved with 100% of the voting shares from all shareholders who attended or authorized their attendance at the meeting.

The AGM was presided over and conducted by the members of the Board of Directors for the term VI (2022 – 2027):

• • Mr. Nguyen Anh Tuan – Chairman of the Board of Directors – Presiding over the General Meeting.
  • Mr. Nguyen Viet Hoang – Independent Board Member

At the meeting, the members of the presidium and the head of the organizing committee presented reports, proposals, and results on the following topics:

1. Change of Board of Directors Members

At the meeting, Mr. Nguyen Anh Tuan, Chairman of the Board of Directors, presented Proposal No. 18-2023/TTr-AGM dated April 12, 2023, from the Board of Directors regarding the resignation of Mr. To Giang Nam as a Board member and the proposal to add new members to the Board of Directors, along with the list of nominees/candidates. The total number of shares approving this proposal was 12,384,193 shares, representing 100% of the shares with voting rights at the meeting.

The results of the vote for the election of additional members to the Board of Directors for Central Veterinary Medicine Joint Stock Company I for Term VI (2022-2027) are as follows:

Nominee Information:

• • Nominee Name: Bui Huong Lien
  • Qualifications: Master’s Degree in Economics and International Business
  • Position Applied For: Board Member

Total Votes Cast: 12 votes, corresponding to 12,384,193 shares, representing 100% of the shares with voting rights at the meeting.

Thus, the elected member of the Board of Directors for Term VI (2022-2027) is Ms. Bui Huong Lien.

Mr. Nguyen Anh Tuan, Chairman of the Board of Directors, presented flowers to the newly elected Board member.

2. **Approval of Proposal No. 19-2023/TTr-AGM dated April 12, 2023** from the Board of Directors regarding the report on the activities of the Board of Directors for the year 2022 and the strategic direction for 2023. The results are as follows: The total number of shares approving the report was 12,384,193 shares, representing 100% of the shares with voting rights at the meeting.

Mr. Nguyen Anh Tuan, Chairman of the Board of Directors, presented the report on the activities of the Board of Directors for 2022 and the strategic direction for 2023.

3. Report on the activities of the Audit Committee for 2022 and the Audit Committee’s task execution plan for 2023.

Approval of Proposal No. 20-2023/TTr-AGM dated April 12, 2023, from the Audit Committee. Presented by Mr. Nguyen Viet Hoang. The total number of shares approving the report was 12,384,193 shares, representing 100% of the shares with voting rights at the meeting.

Mr. Nguyen Viet Hoang, a Board Member, presented the report on the activities of the Audit Committee for 2022 and the Audit Committee’s task execution plan for 2023.

4. In addition to the above-mentioned items, several other key issues were presented and approved at the Annual General Meeting of Shareholders with 100% of the shares with voting rights. Specifically:
   Approval of Proposal No. 21-2023/TTr-AGM dated April 12, 2023, regarding the audited financial statements for 2022.

   Approval of Proposal No. 22-2023/TTr-AGM dated April 12, 2023, regarding the profit distribution plan for 2022 and the proposed profit distribution plan for 2023.

   Approval of Proposal No. 23-2023/TTr-AGM dated April 12, 2023, regarding the settlement of the Board of Directors’ and Audit Committee’s remuneration for 2022 and the proposed remuneration for the Board of Directors and Audit Committee members for 2023.

   Approval of Proposal No. 24-2023/TTr-AGM dated April 12, 2023, regarding the selection of the auditing firm for 2023.

   Approval of Proposal No. 25-2023/TTr-AGM dated April 12, 2023, regarding the amendment of the company’s charter and changes to the business registration contents.

Ms. Vu Thi Hai Hong, Member of the Voting Committee, presented the other contents of the General Meeting.

During the discussion at the General Meeting, heartfelt opinions and concerns of the shareholders regarding the company’s development amidst the current industry difficulties were noted. The Chairman of the Board addressed the shareholders on behalf of the company, outlining the direction and business development plans for the company in the future.

The Annual General Meeting of Shareholders for 2023 of Central Veterinary Medicine Joint Stock Company I concluded successfully at 10:00 AM on the same day.

News: VINAVETCO